Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
2 "Yumi Lee"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Maria Lee, Yumi Lee, Kidong Kim, Eun Young Park, Myong Cheol Lim, Jung-Sup Kim, Hee Seung Kim, Yong-Beom Kim, Yong-Man Kim, Jungnam Joo, Sang Yoon Park, Chel Hun Choi, Jae-Hoon Kim
Cancer Res Treat. 2019;51(1):112-118.   Published online March 7, 2018
DOI: https://doi.org/10.4143/crt.2017.361
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The purpose of this study was to develop Korean versions of the National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy (NCCN-FACT) Ovarian Symptom Index-18 (NFOSI-18) and FACT/Gynecologic Oncology Group (FACT-GOG) Neurotoxicity 4-item (NTX-4), evaluating their reliability and reproducibility.
Materials and Methods
In converting NFOSI-18 and NTX-4, the following steps were performed: forward translation, backward translation, expert review, pretest of preliminary format, and finalization of Korean versions (K-NFOSI-18 and K-NTX-4). Patients were enrolled from six institutions where each had completed chemotherapy for ovarian, tubal, or peritoneal cancer at least 1 month earlier. In addition to demographics obtained by questionnaire, all subjects were assessed via K-NFOSI-18, K-NTX-4, and a Korean version of the EuroQoL-5 Dimension. Internal structural validity and reliability were evaluated using item internal consistency, item discriminant validity, and Cronbach's α. To evaluate test-retest reliability, K-NFOSI-18 and K-NTX-4 were readministered after 7-21 days, and intraclass correlation coefficients (ICCs) were calculated.
Results
Of the 250 women enrolled during the 3-month recruitment period, 13 withdrew or did not respond, leaving 237 (94.8%) for the analyses. Mean patient age was 54.3±10.8 years. Re-testing was performed in 190 patients (80.2%). The total K-NFOSI-18 and K-NTX-4 scores were 49 (range, 20 to 72) and 9 (range, 0 to 16), respectively, with high reliability (Cronbach's α=0.84 and 0.89, respectively) and reproducibility (ICC=0.77 and 0.84, respectively) achieved in retesting.
Conclusion
Both NFOSI-18 and NTX-4 were successfully developed in Korean with minimal modification. Each Korean version showed high internal consistency and reproducibility.

Citations

Citations to this article as recorded by  
  • Peripheral Neuropathy Instruments for Individuals with Cancer: A COSMIN-Based Systematic Review of Measurement Properties
    Silvia Belloni, Arianna Magon, Chiara Giacon, Francesca Savioni, Gianluca Conte, Rosario Caruso, Cristina Arrigoni
    Current Oncology.2024; 31(12): 7828.     CrossRef
  • Assessing the quality of patient-reported outcome measurements for gynecological cancers: a systematic review
    Charlotte L Moss, Teresa Guerrero-Urbano, Ingrid White, Benjamin Taylor, Rebecca Kristeleit, Ana Montes, Louis Fox, Katharina Beyer, Monika Sztankay, Maria M Ratti, Elena S Sisca, Alexandra Derevianko, Steven MacLennan, Nicholas Wood, Lisa M Wintner, Miek
    Future Oncology.2023; 19(9): 663.     CrossRef
  • Validity and Reliability of the Turkish Version of National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Ovarian Symptom Index-18 (NFOSI-18) and Neurotoxicity-4 (NTX-4) for Patients with Advanced Ovarian Cancer
    Husnu Tore Yavuzsen, Sukriye Cansu Gulteki̇n, Karya Polat, Murat Keser, Zeynep Gulsum Guc, Merve Keskinkilic, Tugba Yavuzsen, Didem Karadibak, Sourav Panja
    European Journal of Cancer Care.2023; 2023: 1.     CrossRef
  • Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use
    Tiffany Li, Susanna B. Park, Eva Battaglini, Madeleine T. King, Matthew C. Kiernan, David Goldstein, Claudia Rutherford
    Quality of Life Research.2022; 31(11): 3091.     CrossRef
  • Influence of chemotherapy on postural control and quality of life in women with gynaecological cancer: a protocol of a prospective observational study
    Aline Reinmann, Anne-Violette Bruyneel, Joseph Gligorov, Serge Mesure, Christophe Combescure, Thibaud Koessler, Alexandre Bodmer
    BMJ Open.2022; 12(9): e061664.     CrossRef
  • 8,261 View
  • 185 Download
  • 5 Web of Science
  • 5 Crossref
Close layer
Comparison of Quality of Life and Sexuality between Cervical Cancer Survivors and Healthy Women
Yumi Lee, Myong Cheol Lim, Se Ik Kim, Jungnam Joo, Dong Ock Lee, Sang-Yoon Park
Cancer Res Treat. 2016;48(4):1321-1329.   Published online February 12, 2016
DOI: https://doi.org/10.4143/crt.2015.425
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study is to compare quality of life (QoL) and sexual functioning between sexually active cervical cancer survivors and healthy women.
Materials and Methods
In this cross-sectional study, propensity-score-matched cervical cancer survivors (n=104) and healthy women (n=104) were compared. All women had engaged in sexual activity within the previous 3 months, and cervical cancer survivors showed no evidence of disease after primary treatment. QoL and sexual functioning were assessed using three questionnaires; the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30), Cervical Cancer Module (EORTC QLQ-CX24), and the Female Sexual Function Index (FSFI).
Results
Significantly higher scores for lymphedema were observed in the cervical cancer survivors group compared with the healthy women group (mean, 20.2 vs. 12.2; p < 0.05). Sexuality, both in terms of sexual activity, sexual enjoyment, and sexual worry (EORTC QLQ-CX24), and in terms of desire, arousal, lubrication, orgasm, satisfaction, and pain (FSFI) were similar between the groups. When the scale of sexual/vaginal functioning in EORTC QLQ-CX24 was divided into individual questions, cervical cancer survivors reported shorter vaginal length than the control group, but without statistical significance (mean, 80.6 vs. 85.4; p=0.077).
Conclusion
Compared with healthy women, sexuality was not impaired in cervical cancer survivors who showed no evidence of disease after primary treatment and engaging in sexual activity. Further prospective cohort studies are warranted to confirm this finding.

Citations

Citations to this article as recorded by  
  • Longitudinal study on quality of life following cervical cancer treatment in Botswana
    Surbhi Grover, Rohini K Bhatia, Salman Khan, Paseka Tladi, Lesego Gabaitiri, Memory Bvochora-Nsingo, Sebathu Chiyapo, Dawn Balang, Shalini Vinod, Mark N Polizzotto, Natalie Taylor, Karen Canfell, Nicola Zetola, Doreen Ramogola-Masire, Lilie L Lin, Erle Ro
    BMJ Global Health.2025; 10(3): e017206.     CrossRef
  • The feasibility and acceptability of delivering and evaluating a physical activity intervention (ACCEPTANCE) for cervical cancer survivors
    Nessa Millet, Hilary J. McDermott, Fehmidah Munir, Charlotte L. Edwardson, Tatiana Plekhanova, Esther L. Moss
    Pilot and Feasibility Studies.2025;[Epub]     CrossRef
  • Sexual quality of life between healthy women and women with gynecological cancer: Results of a hospital‐based case–control study in Türkiye
    Ekin Dila Topaloğlu Ören, Selin Kiziltaş
    Journal of Obstetrics and Gynaecology Research.2024; 50(3): 456.     CrossRef
  • Quality of life in long-term cervical cancer survivors compared with healthy women and women with benign gynecological disorders
    Jorge Cea García, Inmaculada Rodríguez Jiménez, Francisco Márquez Maraver, Laura Ríos-Pena, M. Carmen Rubio Rodríguez
    European Journal of Obstetrics & Gynecology and Reproductive Biology.2024; 297: 78.     CrossRef
  • Pre- and Post-Treatment Quality of Life Among Patients with Advanced Stage Cervical Cancer at Tikur Anbessa Specialized Hospital, Ethiopia
    Roza Teshome, Irene Yang, Edom Woldetsadik, Eshetu Girma, Melinda Higgins, Jessica Wells
    Cancer Management and Research.2024; Volume 16: 311.     CrossRef
  • Female sexual function in long-term cervical cancer survivors compared with healthy women and women affected by benign gynecological disorders
    Jorge Cea García, Francisco Márquez Maraver, Inmaculada Rodríguez Jiménez, Laura Ríos-Pena, M. Carmen Rubio Rodríguez
    European Journal of Obstetrics & Gynecology and Reproductive Biology.2024; 299: 43.     CrossRef
  • Prevalence of sexual dysfunction in women with cervical cancer: a systematic review and meta-analysis
    Maolin Qian, Lan Wang, Jiajun Xing, Xiao Shan, Juan Wu, Xiaoqin Liu
    Psychology, Health & Medicine.2023; 28(2): 494.     CrossRef
  • Trends and future projections of cervical cancer‐related outcomes in Japan: What happens if the HPV vaccine program is not implemented?
    Atsuko Sakakibara, Takeo Nakayama, Hiroyuki Uchida, Youichi Odagiri, Yuri Ito, Toshiro Katayama, Yutaka Ueda, Toshihiro Higuchi, Koichi Terakawa, Kunihiko Matsui, Kikuko Miyazaki, Ikuo Konishi
    International Journal of Cancer.2023; 152(9): 1863.     CrossRef
  • Post Treatment Sexual Function and Quality of Life of Patients Affected by Cervical Cancer: A Systematic Review
    Stefano Cianci, Mattia Tarascio, Martina Arcieri, Marco La Verde, Canio Martinelli, Vito Andrea Capozzi, Vittorio Palmara, Ferdinando Gulino, Salvatore Gueli Alletti, Giuseppe Caruso, Stefano Restaino, Giuseppe Vizzielli, Carmine Conte, Marco Palumbo, Alf
    Medicina.2023; 59(4): 704.     CrossRef
  • Association between cervical cancer-related anxiety and depression symptoms and health-related quality of life: A Moroccan cross-sectional study
    Asmaa Azizi, Doha Achak, Amal Boutib, Samia Chergaoui, Elmadani Saad, Abderraouf Hilali, Amr S. Soliman, Ibtissam Youlyouz-Marfak, Abdelghafour Marfak
    Clinical Epidemiology and Global Health.2023; 22: 101328.     CrossRef
  • Impacto del cáncer de cuello uterino en la sexualidad femenina
    Camilla R. Albæk-Jakobsen, Pere Fusté-Brull
    Medicina.2023; 24(2): 21.     CrossRef
  • Sexual Behaviors and Intimate Relationships of Sexual Partners of Young Patients with Early-Stage Cervical Cancer: A Qualitative Study
    Mingyue Li, Dongyang Wang, Jiaxiang Huang, Shunlian Luan, Qinghua Wang
    International Journal of General Medicine.2023; Volume 16: 5377.     CrossRef
  • Long-term Quality of Life and Sexual Function After Neoadjuvant Chemotherapy and Radical Surgery for Locally Advanced Cervical Cancer
    Innocenza Palaia, Giusi Santangelo, Giuseppe Caruso, Giorgia Perniola, Valentina Tibaldi, Ludovico Muzii, Pierluigi Benedetti Panici, Violante Di Donato
    The Journal of Sexual Medicine.2022; 19(4): 613.     CrossRef
  • The Importance of Social Support, Optimism and Resilience on the Quality of Life of Cancer Patients
    Iván Ruiz-Rodríguez, Isabel Hombrados-Mendieta, Anabel Melguizo-Garín, María José Martos-Méndez
    Frontiers in Psychology.2022;[Epub]     CrossRef
  • Relationship of sexual quality of life and mental well-being in undergraduate women in a Canadian university
    Niki Oveisi, Zeba Khan, Lori A. Brotto
    The Canadian Journal of Human Sexuality.2022; 31(3): 422.     CrossRef
  • Longitudinal Health-Related Quality of Life Study among Cervical Cancer Patients Treated with Radiotherapy
    Małgorzata Pasek, Lilia Suchocka, Grażyna Osuch-Pęcak, Konrad Muzykiewicz, Ewa Iwańska, Helena Kaducakowa, Anna Goździalska, Magdalena Goździalska
    Journal of Clinical Medicine.2021; 10(2): 226.     CrossRef
  • Sexual Function and the Role of Sexual Communication in Women Diagnosed with Cervical Cancer: A Systematic Review
    Magdalena Liberacka-Dwojak, Paweł Izdebski
    International Journal of Sexual Health.2021; 33(3): 385.     CrossRef
  • Contribution of Sociodemographic, Clinical, and Psychological Variables to Quality of Life in Women with Cervical Cancer in the Follow-Up Phase
    Ana Clara Lopes, Rosário Bacalhau, Martim Santos, Marta Pereira, M. Graça Pereira
    Journal of Clinical Psychology in Medical Settings.2020; 27(3): 603.     CrossRef
  • Health-related quality of life and associated factors among cervical cancer patients at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia
    Liya Teklu Araya, Teferi Gedif Fenta, Beate Sander, Girma Tekle Gebremariam, Gebremedhin Beedemariam Gebretekle
    Health and Quality of Life Outcomes.2020;[Epub]     CrossRef
  • Le retentissement du cancer utérin et ses traitements sur la sexualité
    A. Ghorbel, A. Yousfi, R. Abidi, S. Yahyaoui, S. Zaraa, K. Mahjoubi, A. Belaid, W. Gargouri, C. Nasr
    Sexologies.2020; 29(4): 186.     CrossRef
  • Survey of the desire to have children and engage in sexual activity after trachelectomy among young Japanese women with early‐stage cervical cancer
    Hideaki Yahata, Kenzo Sonoda, Kaoru Okugawa, Hiroshi Yagi, Tatsuhiro Ohgami, Masafumi Yasunaga, Ichiro Onoyama, Eisuke Kaneki, Kazuo Asanoma, Kiyoko Kato
    Journal of Obstetrics and Gynaecology Research.2019; 45(11): 2255.     CrossRef
  • Qualidade de vida e fatores associados em mulheres sobreviventes ao câncer do colo do útero
    Camila Soares Lima Corrêa, Isabel Cristina Gonçalves Leite, Anna Paula Silva Andrade, Simone Meira Carvalho, Ricardo Miranda Borges, Maximiliano Ribeiro Guerra
    HU Revista.2019; 43(4): 307.     CrossRef
  • The EOLO (End-of-Life Ovarian Cancer) Study: Approach to Ovarian Cancer Patients at the End of Life
    Innocenza Palaia, Federica Tomao, Giusi Santangelo, Anna Di Pinto, Carolina Maria Sassu, Giorgia Perniola, Angela Musella, Violante Di Donato, Antonella Giancotti, Pierluigi Benedetti Panici
    Oncology.2019; 97(5): 306.     CrossRef
  • Vaginal development and sexual functioning in young women after stem cell transplantation, chemotherapy, and/or radiotherapy for childhood hematological diseases
    Fausta Beneventi, Elena Locatelli, Margherita Simonetta, Chiara Cavagnoli, Raffaella Pampuri, Camilla Bellingeri, Irene De Maggio, Beatrice Ruspini, Santina Recupero, Giovanna Giorgiani, Arsenio Spinillo
    Bone Marrow Transplantation.2018; 53(9): 1157.     CrossRef
  • Cross-cultural adaptation and validation of the Functional Assessment of Chronic Illness Therapy – Cervical Dysplasia (FACIT-CD) questionnaire for Serbian women
    Vesna Kesić, Radmila Sparić, Rafal Watrowski, Jelena Dotlić, Radomir Stefanović, Gorica Marić, Tatjana Pekmezović
    European Journal of Obstetrics & Gynecology and Reproductive Biology.2018; 226: 7.     CrossRef
  • Percutaneous parametrial dose escalation in women with advanced cervical cancer: feasibility and efficacy in relation to long-term quality of life
    Sati Akbaba, Jan Tobias Oelmann-Avendano, Tilman Bostel, Harald Rief, Nils Henrik Nicolay, Juergen Debus, Katja Lindel, Robert Foerster
    Radiology and Oncology.2018; 52(3): 320.     CrossRef
  • Attitudes Regarding HPV Vaccinations of Children among Mothers with Adolescent Daughters in Korea
    Kyong-No Lee, Kylie Hae-Jin Chang, Seong-Sik Cho, Sung-Ho Park, Sung Taek Park
    Journal of Korean Medical Science.2017; 32(1): 130.     CrossRef
  • Impact of Ospemifene on Quality of Life and Sexual Function in Young Survivors of Cervical Cancer: A Prospective Study
    Nicoletta De Rosa, Giada Lavitola, Pierluigi Giampaolino, Ilaria Morra, Carmine Nappi, Giuseppe Bifulco
    BioMed Research International.2017; 2017: 1.     CrossRef
  • Körperliche Beschwerden und psychosoziale Folgen nach einer Zervixkarzinomerkrankung
    Kristina Geue, Elisabeth Sowa, Susanne Kuhnt
    Der Onkologe.2016; 22(10): 780.     CrossRef
  • 13,512 View
  • 391 Download
  • 33 Web of Science
  • 29 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP